You finally got the prescription. Your doctor looked at your health history, your labs, your weight, your blood sugar — everything — and decided that Ozempic®, Wegovy®, Mounjaro®, or Zepbound® was the right medication for you. You felt a flicker of hope.
Then the pharmacy called. Denied.
The reason buried in the paperwork: something called "step therapy." Maybe you've never heard of it. Maybe you've heard the term but have no idea what it actually means or why your insurance company suddenly gets to override your doctor's judgment.
Here's everything you need to know — in plain language, no insurance jargon required.
The Basic Idea: You Have to Fail First
Step therapy goes by several names. Insurance companies call it "step therapy" or "step protocol." Doctors and pharmacists often call it "fail first." That second name tells you a lot more about what it actually involves.
The concept is this: before your insurance will pay for the medication your doctor prescribed, they require you to try one or more cheaper alternatives first. If those alternatives don't work — or if they cause side effects you can't tolerate — you can then "step up" to the medication your doctor originally wanted you on.
Think of it like a ladder. Your insurer puts you on the bottom rung and makes you climb, one step at a time, before they'll cover what's at the top.
For GLP-1 medications like Wegovy or Zepbound, those bottom rungs typically include older, cheaper weight loss or diabetes drugs — things like metformin, phentermine, Qsymia, Orlistat, or Saxenda. Your insurance wants documentation that you've tried these options and either didn't respond well or experienced problems with them before they'll agree to cover a GLP-1.
Why Does Insurance Do This?
The honest answer: money.
GLP-1 medications are expensive. A monthly supply of Wegovy or Zepbound can cost anywhere from $900 to over $1,300 without insurance coverage. Insurers are looking for ways to manage that cost, and step therapy is one of their most common tools.
The argument insurance companies make is that step therapy ensures patients try less expensive, "clinically appropriate" options before moving to higher-cost drugs. They frame it as protecting you from unnecessary medication when cheaper alternatives might work just as well.
The argument most doctors and patient advocates make is considerably different. They'll point out that step therapy takes treatment decisions out of the hands of the physician who actually knows you — your health history, your previous medications, your specific conditions — and hands those decisions to an insurance administrator who has never met you and is working from a cost-focused checklist.
When your doctor prescribed a GLP-1, they did so because they believed it was the right choice for your particular situation. Step therapy says: we don't trust that judgment until you've proven cheaper options won't work.
What Step Therapy Actually Looks Like in Practice
Imagine your doctor prescribes Wegovy because you have a BMI over 30, high blood pressure, and early signs of insulin resistance. Your insurance sends back a denial citing step therapy requirements. The denial letter lists three medications you're required to try first — let's say phentermine, Orlistat, and metformin — for a specified period of time before they'll consider approving Wegovy.
You have a few choices at this point. You can comply, work through the required medications, document the results, and then resubmit. You can appeal on the grounds that step therapy is medically inappropriate for your situation. Or you can do nothing — which is what, unfortunately, many patients do, because the process feels overwhelming and the paperwork is confusing.
According to research, 85% of patients who receive a step therapy denial never appeal it. That's exactly what insurance companies are counting on.
When Step Therapy Can Be Challenged
Step therapy is not automatically the final word. There are legitimate situations where you can — and should — push back.
You've already tried those medications. If you took metformin three years ago under a previous insurance plan and it caused severe gastrointestinal side effects, you have grounds to argue that requiring you to try it again is medically unnecessary. Documentation is key here — you'll need records showing the dates, the dosage, and exactly what happened.
The required drugs are medically contraindicated for you. If your doctor can document that the step therapy medications pose specific risks given your health profile — for example, certain weight loss medications are not appropriate for people with specific cardiac conditions or a history of eating disorders — that is grounds for a step therapy exception.
You have a condition that makes waiting dangerous. If your health situation is urgent enough that delaying treatment while you work through a step therapy ladder creates real medical risk, that argument can be made in an appeal.
Your state has step therapy protection laws. This is one that surprises a lot of people. Many states have passed laws that limit how insurance companies can use step therapy and require them to offer exception processes. New Jersey, for example, enacted step therapy reform legislation effective January 1, 2026, placing guardrails on how insurers apply step therapy in state-regulated health plans. Over the past few years, roughly half of US states have introduced some form of step therapy reform. If you live in one of those states and your plan is state-regulated, you have specific legal rights that your insurer must honor.
The catch: these state protections generally don't apply to self-funded employer health plans, which are governed by federal law rather than state law. If your health coverage comes through a large employer who self-funds their plan, state step therapy laws may not help you. Checking whether your plan is fully insured or self-funded is worth doing early in the appeals process.
How to Request a Step Therapy Exception
If you believe step therapy is inappropriate for your situation, you can formally request an exception rather than going through the full fail-first process. This is not the same as filing an appeal after a denial — it's a proactive request, made at the same time as or shortly after the initial denial, arguing that you should be exempt from the step therapy requirement entirely.
A step therapy exception request is most effective when it includes a letter of medical necessity from your doctor explaining why the prescribed GLP-1 is specifically appropriate for you, documentation of any prior medications you've tried (with dates and outcomes), a clear statement of why the step therapy medications are not appropriate alternatives in your case, and any supporting clinical evidence — studies, FDA guidance, or clinical guidelines — that reinforce your doctor's reasoning.
Your insurance company is required to respond to exception requests within a defined timeframe. For urgent requests, that window is typically 24 to 72 hours. For standard requests, it's usually several business days. If they deny the exception, you move into the formal appeals process.
The Bigger Picture: Step Therapy Is Being Challenged Nationally
It's worth knowing that step therapy for GLP-1 medications is increasingly under scrutiny at both the state and federal level.
As of early 2026, at least 14 states have introduced legislation or taken regulatory action to expand access to GLP-1 medications and limit the ways insurers can use step therapy and prior authorization to block coverage. North Dakota became the first state to mandate insurance coverage for GLP-1 medications outright, and several other states are actively working through similar legislation.
At the federal level, the Medicare GLP-1 Bridge program announced in December 2025 will begin in July 2026, providing eligible Medicare beneficiaries with early access to certain GLP-1 medications for obesity alongside a broader coverage expansion expected in 2027.
None of this helps you right now, today, with a denial letter sitting on your kitchen counter. But it does tell you something important: the insurance landscape around GLP-1 medications is quickly changing. The denials and step therapy requirements that are common today may be significantly less common within the next few years.
What You Should Do Right Now
If you've received a step therapy denial for a GLP-1 medication, the most important thing is not to ignore it. Denials have appeal deadlines — typically 180 days from the denial date — and waiting too long can close off your options.
Start by reading your denial letter carefully. It should specify the exact step therapy medications your insurer requires, the timeframe for trying them, and the criteria for moving forward. Call your insurance company to clarify anything that's unclear, and make sure you understand whether your plan is state-regulated or self-funded, since that determines which protections apply to you.
Talk to your prescribing doctor. They may be willing to submit a peer-to-peer review request, where they speak directly with your insurance company's medical reviewer to argue for your case. Physician-to-physician conversations are often more persuasive than written appeals alone, and many insurers are required to offer this option.
And document everything. Every call, every letter, every piece of medical history that supports your case. Step therapy denials can be overturned — but only when patients show up prepared, persistent, and informed.
Get the GLP-1 Insurance Appeal Toolkit today and get everything you need to appeal your step therapy denial.